QQQ   348.70 (-0.37%)
AAPL   179.10 (+1.02%)
MSFT   330.61 (-0.18%)
META   263.66 (+0.43%)
GOOGL   123.16 (-0.41%)
AMZN   120.14 (-1.25%)
TSLA   199.72 (-0.72%)
NVDA   385.57 (-3.87%)
NIO   7.37 (-0.54%)
BABA   79.38 (+0.90%)
AMD   120.04 (-4.17%)
T   15.79 (+0.96%)
F   12.06 (-4.21%)
MU   68.58 (-4.34%)
CGC   0.81 (-4.30%)
GE   100.78 (-1.58%)
DIS   87.87 (+0.06%)
AMC   4.46 (-3.67%)
PFE   37.84 (+2.24%)
PYPL   61.79 (-0.42%)
NFLX   395.45 (+0.63%)
QQQ   348.70 (-0.37%)
AAPL   179.10 (+1.02%)
MSFT   330.61 (-0.18%)
META   263.66 (+0.43%)
GOOGL   123.16 (-0.41%)
AMZN   120.14 (-1.25%)
TSLA   199.72 (-0.72%)
NVDA   385.57 (-3.87%)
NIO   7.37 (-0.54%)
BABA   79.38 (+0.90%)
AMD   120.04 (-4.17%)
T   15.79 (+0.96%)
F   12.06 (-4.21%)
MU   68.58 (-4.34%)
CGC   0.81 (-4.30%)
GE   100.78 (-1.58%)
DIS   87.87 (+0.06%)
AMC   4.46 (-3.67%)
PFE   37.84 (+2.24%)
PYPL   61.79 (-0.42%)
NFLX   395.45 (+0.63%)
QQQ   348.70 (-0.37%)
AAPL   179.10 (+1.02%)
MSFT   330.61 (-0.18%)
META   263.66 (+0.43%)
GOOGL   123.16 (-0.41%)
AMZN   120.14 (-1.25%)
TSLA   199.72 (-0.72%)
NVDA   385.57 (-3.87%)
NIO   7.37 (-0.54%)
BABA   79.38 (+0.90%)
AMD   120.04 (-4.17%)
T   15.79 (+0.96%)
F   12.06 (-4.21%)
MU   68.58 (-4.34%)
CGC   0.81 (-4.30%)
GE   100.78 (-1.58%)
DIS   87.87 (+0.06%)
AMC   4.46 (-3.67%)
PFE   37.84 (+2.24%)
PYPL   61.79 (-0.42%)
NFLX   395.45 (+0.63%)
QQQ   348.70 (-0.37%)
AAPL   179.10 (+1.02%)
MSFT   330.61 (-0.18%)
META   263.66 (+0.43%)
GOOGL   123.16 (-0.41%)
AMZN   120.14 (-1.25%)
TSLA   199.72 (-0.72%)
NVDA   385.57 (-3.87%)
NIO   7.37 (-0.54%)
BABA   79.38 (+0.90%)
AMD   120.04 (-4.17%)
T   15.79 (+0.96%)
F   12.06 (-4.21%)
MU   68.58 (-4.34%)
CGC   0.81 (-4.30%)
GE   100.78 (-1.58%)
DIS   87.87 (+0.06%)
AMC   4.46 (-3.67%)
PFE   37.84 (+2.24%)
PYPL   61.79 (-0.42%)
NFLX   395.45 (+0.63%)
NASDAQ:CDNA

CareDx (CDNA) Stock Forecast, Price & News

$7.96
-0.01 (-0.13%)
(As of 02:19 PM ET)
Compare
Today's Range
$7.76
$8.17
50-Day Range
$7.61
$9.46
52-Week Range
$6.22
$27.35
Volume
204,815 shs
Average Volume
1.17 million shs
Market Capitalization
$428.17 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$16.00

CareDx MarketRank™ Forecast

Analyst Rating
Hold
2.20 Rating Score
Upside/​Downside
102.5% Upside
$16.00 Price Target
Short Interest
Bearish
11.97% of Float Sold Short
Dividend Strength
N/A
Sustainability
-0.66
Upright™ Environmental Score
News Sentiment
1.02mentions of CareDx in the last 14 days
Based on 5 Articles This Week
Insider Trading
Selling Shares
$92,877 Sold Last Quarter
Proj. Earnings Growth
Growing
From ($1.73) to ($1.41) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.18 out of 5 stars

Medical Sector

319th out of 1,006 stocks

Medical Laboratories Industry

8th out of 24 stocks


CDNA stock logo

About CareDx (NASDAQ:CDNA) Stock

CareDx, Inc. operates as a transplant diagnostics company, which discovers, develops and commercializes diagnostic solutions. Its products include AlloMap, AlloSure and Laboratory products. The company was founded on December 21, 1998 and is headquartered in Brisbane, CA.

Receive CDNA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CareDx and its competitors with MarketBeat's FREE daily newsletter.

CDNA Stock News Headlines

The Ignored EV Story Few Investors Know About
Lithium may grab all the headlines, but the average electric vehicle requires 146 pounds of the mineral graphite. With no producing graphite mines in North America, the U.S. government is desperate for more domestic sources of the metal to feed the EV battery supply chain.
Should You Exit CareDx (CDNA)?
CareDx (NASDAQ:CDNA) Lowered to "Neutral" at BTIG Research
8-K: CareDx, Inc.
146 Pounds of Graphite Needed for Each EV
Graphite - not lithium - is the largest component of lithium-ion batteries used in electric vehicles. That's why 97 more graphite mines will be needed by 2035 just to keep up with battery demand for the $7 trillion EV market.
BTIG Downgrades Caredx (CDNA)
CareDx (CDNA) Receives a Hold from H.C. Wainwright
A Preview Of CareDx's Earnings
CareDx Reports First Quarter 2023 Results
CareDx (NASDAQ:CDNA) Stock Price Up 8.9%
See More Headlines
Receive CDNA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CareDx and its competitors with MarketBeat's FREE daily newsletter.

CDNA Company Calendar

Last Earnings
10/28/2021
Today
5/31/2023
Next Earnings (Estimated)
8/03/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Medical laboratories
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:CDNA
Employees
633
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$16.00
High Stock Price Forecast
$25.00
Low Stock Price Forecast
$9.00
Forecasted Upside/Downside
+100.8%
Consensus Rating
Hold
Rating Score (0-4)
2.20
Research Coverage
5 Analysts

Profitability

Net Income
$-76,610,000.00
Pretax Margin
-25.09%

Debt

Sales & Book Value

Annual Sales
$321.79 million
Book Value
$8.05 per share

Miscellaneous

Free Float
51,103,000
Market Cap
$428.71 million
Optionable
Optionable
Beta
1.04

Key Executives

  • Reginald SeetoReginald Seeto
    President, Chief Executive Officer & Director
  • Marica Grskovic
    Chief Operations Officer
  • Abhishek Jain
    Chief Financial & Accounting Officer
  • Srini Srinivas
    SVP-Medical Affairs & Clinical Operations
  • Ashish Kothari
    Vice President-Medical Affairs













CDNA Stock - Frequently Asked Questions

Should I buy or sell CareDx stock right now?

5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for CareDx in the last twelve months. There are currently 4 hold ratings and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" CDNA shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CDNA, but not buy additional shares or sell existing shares.
View CDNA analyst ratings
or view top-rated stocks.

What is CareDx's stock price forecast for 2023?

5 analysts have issued 1-year price targets for CareDx's stock. Their CDNA share price forecasts range from $9.00 to $25.00. On average, they expect the company's share price to reach $16.00 in the next twelve months. This suggests a possible upside of 100.8% from the stock's current price.
View analysts price targets for CDNA
or view top-rated stocks among Wall Street analysts.

How have CDNA shares performed in 2023?

CareDx's stock was trading at $11.41 at the start of the year. Since then, CDNA stock has decreased by 30.1% and is now trading at $7.97.
View the best growth stocks for 2023 here
.

Are investors shorting CareDx?

CareDx saw a increase in short interest in the month of May. As of May 15th, there was short interest totaling 6,200,000 shares, an increase of 19.2% from the April 30th total of 5,200,000 shares. Based on an average trading volume of 1,380,000 shares, the short-interest ratio is presently 4.5 days. Currently, 12.0% of the shares of the stock are sold short.
View CareDx's Short Interest
.

When is CareDx's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, August 3rd 2023.
View our CDNA earnings forecast
.

How were CareDx's earnings last quarter?

CareDx, Inc (NASDAQ:CDNA) announced its quarterly earnings results on Thursday, October, 28th. The company reported $0.07 earnings per share for the quarter, beating analysts' consensus estimates of ($0.14) by $0.21. The business earned $75.60 million during the quarter, compared to analysts' expectations of $74.11 million. CareDx had a negative trailing twelve-month return on equity of 18.65% and a negative net margin of 25.25%. The company's revenue was up 41.6% on a year-over-year basis. During the same quarter in the previous year, the business earned ($0.06) EPS.

What other stocks do shareholders of CareDx own?

Based on aggregate information from My MarketBeat watchlists, some companies that other CareDx investors own include Block (SQ), Roku (ROKU), Exact Sciences (EXAS), NVIDIA (NVDA), Advanced Micro Devices (AMD), Tesla (TSLA), Enphase Energy (ENPH), Johnson & Johnson (JNJ), Activision Blizzard (ATVI) and Alibaba Group (BABA).

What is CareDx's stock symbol?

CareDx trades on the NASDAQ under the ticker symbol "CDNA."

Who are CareDx's major shareholders?

CareDx's stock is owned by many different institutional and retail investors. Top institutional investors include ARK Investment Management LLC (12.67%), State Street Corp (9.07%), BlackRock Inc. (8.13%), Armistice Capital LLC (5.83%), Sumitomo Mitsui Trust Holdings Inc. (5.12%) and Nikko Asset Management Americas Inc. (5.12%). Insiders that own company stock include Ankur Dhingra, George Bickerstaff, Grace Colon, Michael Brian Bell, Michael Goldberg, Paul Adler, Peter Maag, Ralph Snyderman, Reginald Seeto, Sasha King, Thomas A Thomas and William A Hagstrom.
View institutional ownership trends
.

How do I buy shares of CareDx?

Shares of CDNA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is CareDx's stock price today?

One share of CDNA stock can currently be purchased for approximately $7.97.

How much money does CareDx make?

CareDx (NASDAQ:CDNA) has a market capitalization of $428.71 million and generates $321.79 million in revenue each year. The company earns $-76,610,000.00 in net income (profit) each year or ($1.51) on an earnings per share basis.

How many employees does CareDx have?

The company employs 633 workers across the globe.

How can I contact CareDx?

CareDx's mailing address is 1 TOWER PLACE 9TH FLOOR, SOUTH SAN FRANCISCO CA, 94080. The official website for the company is www.caredxinc.com. The company can be reached via phone at (415) 287-2300, via email at caroline.corner@westwicke.com, or via fax at 415-287-2450.

This page (NASDAQ:CDNA) was last updated on 5/31/2023 by MarketBeat.com Staff

My Account -